Research Summary
Research Summary
02/14/2025
Kate Young
A recent study suggests that an 8-week online mindfulness program may help alleviate dyspnea in patients with interstitial lung disease, a condition often resistant to conventional treatments.
02/14/2025
Research Summary
Research Summary
02/10/2025
Miranda Manier, BA
A recent study explored the impact of high-flow nasal cannula therapy on exercise tolerance in patients with interstitial lung disease, showing benefits with oxygen supplementation in improving endurance...
02/10/2025
FDA Alert
FDA Alert
01/29/2025
Miranda Manier, BA
The FDA has proposed new draft guidance to improve the accuracy of pulse oximeters across all skin tones, addressing long-standing concerns about potential disparities in performance.
01/29/2025
FDA Alert
FDA Alert
01/28/2025
Anthony Calabro, MA
The FDA is seeking a cap on nicotine levels in cigarettes and certain tobacco products at minimally or nonaddictive levels. This initiative, if finalized, would be what the FDA calls a “significant step”...
01/28/2025
Public Health
Public Health
11/18/2024
Miranda Manier, BA
The CDC has updated its guidelines for COVID-19 and pneumococcal vaccines, aiming to boost protection for high-risk populations against severe disease year-round.
11/18/2024
Research Summary
Research Summary
11/03/2024
Miranda Manier, BA
A prospective study reveals that individuals with inflammatory bowel disease (IBD), ulcerative colitis, and Crohn disease have a significantly higher risk of developing chronic obstructive pulmonary disease...
11/03/2024
Research summary
Research summary
07/11/2024
Jessica Ganga
The American Academy of Otolaryngology-Head and Neck Surgery Foundation released a set of guidelines that outline evidence-based recommendations on the use of immunotherapy for inhalant allergy for...
07/11/2024
Research summary
Research summary
07/10/2024
A team of researchers sought to determine the incidence of inappropriate diagnosis among patients hospitalized and treated for community-acquired pneumonia.
07/10/2024
FDA ALERT
FDA ALERT
04/12/2024

Jessica Bard

Jessica Bard
The FDA has approved sotatercept-csrk, the first activin signaling inhibitor therapy, for the management of patients with pulmonary arterial hypertension (PAH). Based on the Phase 3 STELLAR trial,...
04/12/2024
Research Summary
Research Summary
02/02/2024
Jessica Ganga
Researchers conducted a systematic review to assess the effect of CPAP treatment for obstructive sleep apnea on secondary cardiovascular disease events.
02/02/2024